ha14-1 has been researched along with Ischemia in 1 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q | 1 |
| Xu, H | 1 |
| Xu, A | 1 |
| Ross, T | 1 |
| Bowler, E | 1 |
| Hu, Y | 1 |
| Lesnefsky, EJ | 1 |
1 other study available for ha14-1 and Ischemia
| Article | Year |
|---|---|
Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
Topics: Animals; Benzopyrans; Calcium; Cell Death; Cells, Cultured; Ischemia; Mice; Mitochondria, Heart; Mit | 2015 |